Santarus 10K 2012 Annual report | SNTS Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: alessandro, amoebic, angiodema, Apriso, art, aziothioprine, balsalazide, ban, banc, Bermuda, bioequivalence, bioequivalent, burning, cessation, ch, chest, children, citizen, constipation, contaminated, Corrupt, coupon, della, Dexilant, disability, dissolution, duodenum, dysentery, en, esterase, estoppel, expressly, filer, Florida, French, headache, HRP, Humira, hydrocortisone, IIa, immunosuppressive, inactive, Indian, infection, infusion, ingestion, ITT, Janumet®XR, jurisdiction, jury, Kilroy, Kombiglyze®XR, motion, Mylan, nonsteroidal, pathogenic, Pentasa, persistent, pharmacokinetic, pharmacoscintigraphy, pivotal, prespecified, purported, questionnaire, rabbi, Racketeer, Realty, Reddy, refrain, rehearing, relocation, Remicade, respond, retirement, Ruconest, salary, sensation, shipping, sulfasalzine, symptom, Tanzania, textual, throat, timeline, unforeseeable, unlawful, upheld, vacated, water, Watson

Removed: academic, AG, ascending, auction, azithromycin, bloating, building, CDC, certify, Cipro, claiming, confidence, consequential, cramping, declining, deductibility, disclosing, divulged, dosed, eastern, EC, endoscopy, Entocort, EU, exceeded, exempt, extension, facilitate, failed, half, harmed, home, India, infringed, initiation, innovation, intermittent, investigated, Israel, labor, led, literature, loose, LP, malaise, misclassified, month, mutually, nausea, oil, onset, path, penetrate, powered, precipitated, preparing, ranged, rata, referenced, released, relying, resistance, Restoration, returning, rifaxamin, score, send, serve, short, show, significance, sitagliptin, statistical, steroid, superiority, technological, topical, tract, traveler, traveling, UBS, UCDAI, unemployment, unpatented, unused, urgency, vomiting, watery, western, Xifaxan, Zithromax


Name		Jurisdiction of Incorporation
Covella Pharmaceuticals, Inc.		Delaware

Santarus (SNTS) Inactive 10-K2012 FY Annual report

Content analysis